Download PDF (external access)

European Journal Of Medicinal Chemistry

Publication date: 2016-10-21
Volume: 122 Pages: 786 - 801
Publisher: Elsevier

Author:

Eleftheriadis, Nikolaos
Poelman, Hessel ; Leus, Niek GJ ; Honrath, Birgit ; Neochoritis, Constantinos G ; Dolga, Amalia ; Domling, Alexander ; Dekker, Frank J

Keywords:

Science & Technology, Life Sciences & Biomedicine, Chemistry, Medicinal, Pharmacology & Pharmacy, 15-Lipoxygenase, Thiophene-based inhibitor, Substitution Oriented Screening, Multi component chemistry, Inflammation, Neurodegeneration, ARACHIDONIC-ACID, CELL-DEATH, CNS, 12/15-LIPOXYGENASE, LIPOXYGENASE, INVOLVEMENT, PATHWAY, EXPRESSION, DISEASE, PROTEIN, Animals, Anti-Inflammatory Agents, Cell Line, Dose-Response Relationship, Drug, Lipoxygenase, Lipoxygenase Inhibitors, Mice, Neuroprotective Agents, Thiophenes, 0304 Medicinal and Biomolecular Chemistry, 0305 Organic Chemistry, 1115 Pharmacology and Pharmaceutical Sciences, Medicinal & Biomolecular Chemistry, 3214 Pharmacology and pharmaceutical sciences, 3404 Medicinal and biomolecular chemistry, 3405 Organic chemistry

Abstract:

The enzyme 15-lipoxygenase-1 (15-LOX-1) plays a dual role in diseases with an inflammatory component. On one hand 15-LOX-1 plays a role in pro-inflammatory gene expression and on the other hand it has been shown to be involved in central nervous system (CNS) disorders by its ability to mediate oxidative stress and damage of mitochondrial membranes under hypoxic conditions. In order to further explore applications in the CNS, novel 15-LOX-1 inhibitors with favorable physicochemical properties need to be developed. Here, we present Substitution Oriented Screening (SOS) in combination with Multi Component Chemistry (MCR) as an effective strategy to identify a diversely substituted small heterocyclic inhibitors for 15-LOX-1, denoted ThioLox, with physicochemical properties superior to previously identified inhibitors. Ex vivo biological evaluation in precision-cut lung slices (PCLS) showed inhibition of pro-inflammatory gene expression and in vitro studies on neuronal HT-22 cells showed a strong protection against glutamate toxicity for this 15-LOX-1 inhibitor. This provides a novel approach to identify novel small with favorable physicochemical properties for exploring 15-LOX-1 as a drug target in inflammatory diseases and neurodegeneration.